FV
Insider
Forbion IV Management B.V.
10% ownerForbion IV Management B.V. (10% owner) filed 3 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $4.9M of NAMS (191,762 sh across 3 lots, as filed), executed Dec 12 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.2M
shares × price, as filed
Last traded
Dec 24 2024
Filed Dec 26 2024
Median ADV $32.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $10.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 24 months
Most traded names
NAMSRecent filings
NAMSSALE
NewAmsterdam Pharma Company N.V.
View filing →
$2.3M91,068 sh across 4 lots
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET † NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $3.0M
114,384 sh across 2 lots
Exec Dec 17 2024
Filed Dec 18 2024 · 5:30 PM ET NAMSSALE NewAmsterdam Pharma Company N.V. View filing → $4.9M
191,762 sh across 3 lots
Exec Dec 12 2024
Filed Dec 16 2024 · 5:30 PM ET